Bapotulimab (BAY-1905254) is a human/mouse/monkey cross-reactive monoclonal antibody that targets and inhibits ILDR2 (immunoglobulin-like domain containing receptor 2), blocking its immunosuppressive activity for cancer immunotherapy. Bapotulimab promotes T-cell activation in mice, enhancing antigen-specific T-cell proliferation and cytotoxicity.
Purity:
95.00%
CAS Number:
[2359413-58-2]
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted